TP53 signature predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: Observational and confirmational study using prospective study cohorts-Reference-Cited by-同舟云学术

TP53 signature predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: Observational and confirmational study using prospective study cohorts

Published:2024-10 Issue: Volume:48 Page:102060
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Takahashi Shin^ORCID,Sato Nobuaki,Kaneko Kouji^ORCID,Masuda Norikazu,Kawai Masaaki^ORCID,Hirakawa Hisashi,Nomizu Tadashi,Iwata Hiroji,Ueda Ai,Ishikawa Takashi,Bando Hiroko,Inoue Yuka,Ueno Takayuki^ORCID,Ohno Shinji,Kubo Makoto,Yamauchi Hideko,Okamoto Masahiro,Tokunaga Eriko,Kamigaki Shunji,Aogi Kenjiro,Komatsu Hideaki,Kitada Masahiro,Uemoto Yasuaki^ORCID,Toyama Tatsuya,Yamamoto Yutaka^ORCID,Yamashita Toshinari^ORCID,Yanagawa Takehiro,Yamashita Hiroko,Matsumoto Yoshiaki^ORCID,Toi Masakazu,Miyashita Minoru^ORCID,Ishida Takanori,Fujishima Fumiyoshi,Sato Satoko,Yamaguchi Takuhiro^ORCID,Takahashi Fumiaki,Ishioka Chikashi^ORCID

Publisher

Elsevier BV

Reference37 articles.

1. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group;Lancet,1998

2. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials;Bernard Asselain;Lancet Oncol.,2018

3. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27;Rastogi;J. Clin. Oncol.,2008

4. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes;von Minckwitz;J. Clin. Oncol.,2012

5. Adjuvant capecitabine for breast cancer after preoperative chemotherapy;Masuda;N. Engl. J. Med.,2017